Shyld AI raised $13.4 million to expand its AI-powered UV disinfection platform that autonomously sanitizes hospital rooms. The company positioned the technology as a way to reduce healthcare-associated infection risk while lowering reliance on labor-intensive cleaning workflows. The funding underscores how life science-adjacent health tech is increasingly competing for operational improvements inside clinical facilities, especially where measurable outcomes such as infection rates and cleaning coverage can be tied to automation. For hospital procurement and clinical operations, this kind of capital-backed deployment model can accelerate the migration from manual processes to monitored, repeatable disinfection systems.